TY  - GEN
AU  - Rager,A
AU  - Frey,N
AU  - Goldstein,S C
AU  - Reshef,R
AU  - Hexner,E O
AU  - Loren,A
AU  - Luger,S M
AU  - Perl,A
AU  - Tsai,D
AU  - Davis,J
AU  - Vozniak,M
AU  - Smith,J
AU  - Stadtmauer,E A
AU  - Porter,D L
TI  - Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD
SN  - 1476-5365
PY  - 2011///0804
KW  - Acute Disease
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Daclizumab
KW  - Drug Resistance
KW  - Female
KW  - Graft vs Host Disease
KW  - drug therapy
KW  - Humans
KW  - Immunoglobulin G
KW  - Immunosuppressive Agents
KW  - Infliximab
KW  - Male
KW  - Middle Aged
KW  - Prognosis
KW  - Retrospective Studies
KW  - Steroids
KW  - pharmacology
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1038/bmt.2010.117
ER  -